ThuLEP technique for managing benign prostatic hyperplasia: Intraoperative and postoperative complications in a series of 42 consecutive cases
Complications in ThuLEP technique
Keywords:
ThuLEP, benign prostatic enlargement, transurethral resectionAbstract
Background/Aim: Data from the first series of 42 patients diagnosed with benign prostatic hyperplasia (BPH) who underwent Thulium laser prostate enucleation (ThuLEP) surgery at our clinic were retrospectively reviewed. The procedures were performed by a single physician with 10 years of endoscopic surgery experience. The purpose of this retrospective study was to add our results, which highlight potential complications during and after ThuLEP surgery, to the already reported ThuLEP results in the literature.
Methods: Data from 42 patients with BPH who underwent ThuLEP surgery at Atlas University Hospital between January 2020 and January 2024 were retrospectively analyzed. Patients with a high international prostate symptom score (IPSS>7), a low quality of life score (QoL<3), a prostate volume ≥ 50 cc according to urinary ultrasonography, a peak urine flow rate (Qmax) ≤ 15 ml/s on uroflowmetry, a total serum prostate-specific antigen (tPSA) <4 ng/mL, and a negative biopsy tPSA ≥ 4 ng/mL were included in the study. All patients underwent pre-operative evaluations that included urinalysis, urine culture, tPSA, uroflowmetry, IPSS, QoL, urinary ultrasonography, prostate volume, postvoid residual urine volume (PVR), and sexual function (IIEF). ThuLEP surgery was performed en bloc using the “Omega Sign” technique in all patients.
Results: Mean enucleation and morcellation times were 110±40 and 25±18 min, respectively. Mean resected prostate tissue weight was 40±25 g. Mean hospital stay and catheterization time were 40±12 and 36±10 h, respectively. Significant improvements were observed in post-operative IPSS, IIEF, QoL, Qmax, and PVR (P<0.05). Qmax increased, whereas PVR decreased. Post-operative hemoglobin values decreased initially (P<0.05) but returned to baseline at six months (P>0.05). Intra-operative complications included superficial bladder mucosal injury in two patients (4.76%), major capsular perforation in one patient (2.38%), and major perforation below the bladder neck between the five and seven o'clock positions in one patient (2.38%). Complications that developed in the first six months after surgery included urinary retention in one patient (2.38%), stress incontinence in two patients (4.76%), and urethral stricture in one patient (2.38%).
Conclusion: Due to the steep learning curve for surgeons, ThuLEP surgery can initially cause complications, which are manageable. Despite these complications, current reports support its safety and effectiveness across a variety of prostate sizes. The ThuLEP technique offers patients several advantages, such as shorter hospital stays, shorter catheterization times, and fewer complications.
Downloads
References
Netsch C, Bach T, Pohlmann L, Herrmann T, Gross AJ. Comparison of 120-200 W 2 μm thulium:yttrium-aluminum-garnet vapoenucleation of the prostate. J Endourol. 2012 Mar;26(3):224-9. doi: 10.1089/end.2011.0173. Epub 2012 Jan 25. PMID: 22191688.
Management of Non-neurogenic Male LUTS. EAU Guidelines. Edn. presented at the EAU Annual Congress Paris April 2024. ISBN 978-94-92671-23-3.
Pirola GM, Saredi G, Codas Duarte R, Bernard L, Pacchetti A, Berti L, et al. Holmium laser versus thulium laser enucleation of the prostate: a matched-pair analysis from two centers. Ther Adv Urol. 2018 Jun 7;10(8):223-33. doi: 10.1177/1756287218779784. PMID: 30034541; PMCID: PMC6048626.
Trama F, Lauro GD, Illiano E, Iacono F, Romis L, Mordente S, et al. Ejaculation Sparing Thulium Laser Enucleation of the Prostate: An Observational Prospective Study. J Clin Med. 2022 Oct 28;11(21):6365. doi: 10.3390/jcm11216365. PMID: 36362593; PMCID: PMC9658552.
Hou CP, Lin YH, Juang HH, Chang PL, Chen CL, Yang PS, et al. Clinical outcome of transurethral enucleation of the prostate using the 120-W thulium Laser (Vela™ XL) compared to bipolar transurethral resection of the prostate (TURP) in aging male. Aging (Albany NY). 2020 Jan 28;12(2):1888-98. doi: 10.18632/aging.102720. Epub 2020 Jan 28. PMID: 31991402; PMCID: PMC7053585.
Yang Z, Liu T, Wang X. Comparison of thulium laser enucleation and plasmakinetic resection of the prostate in a randomized prospective trial with 5-year follow-up. Lasers Med Sci. 2016 Dec;31(9):1797-802. doi: 10.1007/s10103-016-2052-2. Epub 2016 Sep 27. PMID: 27677474.
Elmansy H, Baazeem A, Kotb A, Badawy H, Riad E, Emran A, Elhilali M. Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial. J Urol. 2012 Jul;188(1):216-21. doi: 10.1016/j.juro.2012.02.2576. Epub 2012 May 15. PMID: 22591968.
Spaliviero M, Strom KH, Gu X, Araki M, Culkin DJ, Wong C. Does Greenlight HPS(™) laser photoselective vaporization prostatectomy affect sexual function? J Endourol. 2010 Dec;24(12):2051-7. doi: 10.1089/end.2010.0296. Epub 2010 Oct 21. PMID: 20964486.
Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int. 2010 Apr;105(7):964-9. doi: 10.1111/j.1464-410X.2009.08961.x. Epub 2009 Nov 12. PMID: 19912196.
Hossack TA, Woo HH. Sexual function outcome following photoselective vaporisation of the prostate. Int Urol Nephrol. 2012 Apr;44(2):359-64. doi: 10.1007/s11255-011-0029-4. Epub 2011 Jul 21. PMID: 21779921.
Kumar A, Vasudeva P, Kumar N, Nanda B, Mohanty NK. Evaluation of the Effect of Photoselective Vaporization of the Prostate on Sexual Function in a Prospective Study: A Single Center Experience of 150 Patients. J Endourol. 2012 Oct 9. doi: 10.1089/end.2012.0376. Epub ahead of print. PMID: 22849319.
Bruyère F, Puichaud A, Pereira H, Faivre d'Arcier B, Rouanet A, Floc'h AP, et al. Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol. 2010 Aug;58(2):207-11. doi: 10.1016/j.eururo.2010.04.027. Epub 2010 May 6. PMID: 20466480.
Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol. 2006 Sep;50(3):563-8. doi: 10.1016/j.eururo.2006.04.003. Epub 2006 May 2. PMID: 16713070.
Carmignani L, Bozzini G, Macchi A, Maruccia S, Picozzi S, Casellato S. Sexual outcome of patients undergoing thulium laser enucleation of the prostate for benign prostatic hyperplasia. Asian J Androl. 2015 Sep-Oct;17(5):802-6. doi: 10.4103/1008-682X.139255. PMID: 25652616; PMCID: PMC4577594.
Franz J, Suarez-Ibarrola R, Pütz P, Sigle A, Lusuardi L, Netsch C, et al. Morcellation After Endoscopic Enucleation of the Prostate: Efficiency and Safety of Currently Available Devices. Eur Urol Focus. 2022 Mar;8(2):532-44. doi: 10.1016/j.euf.2021.03.021. Epub 2021 Apr 12. PMID: 33858810.
Chen Y, Xu H, Gao D, Gu M, Liu C, Zhan M, et al. A prospective randomized controlled trial comparing the effect and safety of Piranha and VersaCut morcellation devices in transurethral holmium laser enucleation of the prostate. International Urology and Nephrology. 2022 Nov;54(11):2977-81. DOI: 10.1007/s11255-022-03218-0. PMID: 35596886.
DeLay KJ, Nutt M, McVary KT. Ejaculatory dysfunction in the treatment of lower urinary tract symptoms. Transl Androl Urol. 2016 Aug;5(4):450-9. doi: 10.21037/tau.2016.06.06. PMID: 27652217; PMCID: PMC5002000.
Krambeck AE, Handa SE, Lingeman JE. Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol. 2013 Jan;189(1 Suppl):S141-5. doi: 10.1016/j.juro.2012.11.027. PMID: 23234620.
Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023. J Urol. 2024 Jan;211(1):11-9. doi: 10.1097/JU.0000000000003698. Epub 2023 Sep 14. PMID: 37706750.
Downloads
- 7 2
Published
Issue
Section
How to Cite
License
Copyright (c) 2025 Müslüm Ergün, Süleyman Sağır, İbrahim Hacıbey
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.